Sign In
Buy BNGO
$1.12
+0.0050 (+0.448%)
At Close: Aug 04, 2026
BioNano Genomics (BNGO) Receives a Buy from Oppenheimer - Markets
01:33am, Friday, 19'th Jun 2020
In a report released yesterday, Kevin DeGeeter from Oppenheimer maintained a Buy rating on BioNano Genomics (BNGO – Research Report),
The Daily Biotech Pulse: Tiziana Snags A Patent Win, Decision Day For Nabriva And Evoke, IPOs
12:00am, Friday, 19'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 18)
ADC Therapeutics SA (NYSE:...
Bionano Genomics, Inc.'s (BNGO) CEO Dr. Erik Holmlin on Q1 2020 Results - Earnings Call Transcript
11:48pm, Thursday, 18'th Jun 2020
Bionano Genomics, Inc. (NASDAQ:BNGO) Q1 2020 Results Earnings Conference Call June 18, 2020, 4:30 PM ET Company Participants Monique Kosse - Investor Relations
Bionano Genomics Reports First Quarter 2020 Financial Results and Provides Business Update
08:01pm, Thursday, 18'th Jun 2020
SAN DIEGO, June 18, 2020 -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and.
Bionano Announces Amendment to Proxy Statement for Annual Meeting of Stockholders
12:00pm, Thursday, 18'th Jun 2020
Bionano Genomics, Inc. (BNGO) today announced that on June 17, 2020 it filed an amendment to its Proxy Statement for its 2020 Annual Meeting of Stockholders in order to amend and supplement Proposal 1
The Daily Biotech Pulse: Eloxx Resumes Cystic Fibrosis Study, Rexahn's Reverse Merger, Ultragenyx, Epizyme Await FDA Decisions
12:00am, Thursday, 18'th Jun 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 17)
Adverum Biotechnologies Inc...
The Week Ahead In Biotech: FDA Decisions In The Cards For Merck, Epizyme, Evoke And Ultragenyx
12:00am, Sunday, 14'th Jun 2020
Biotech stocks came under pressure along with the broader market in the week ended June 12, as a worsening pandemic situation and its impact on the economy led to an across-the-...
Bionano Genomics to Report First Quarter 2020 Financial Results and Host a Conference Call and Webcast on June 18
12:46pm, Friday, 12'th Jun 2020
SAN DIEGO, June 12, 2020 -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and.
Bionano Genomics, Inc. (BNGO) today announced that three top cytogeneticists from leading institutions in The Netherlands and Germany presented data at the 2020 European Society of Human Genetics (ESH
Bionano Genomics Announces Issuance of US Patent for Combined Nanochannel-Nanopore Device
12:00pm, Monday, 08'th Jun 2020
Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that the United States Patent and Trademark Office will issue US Patent No. 10,676,352 on June 9th, 2020.
What Makes Bionano Genomics, Inc. (BNGO) a New Strong Buy Stock
04:00pm, Thursday, 28'th May 2020
Bionano Genomics, Inc. (BNGO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
Bionano to Participate in Maxim Group’s Covid-19 Virtual Conference Series: The Role of Cell Therapy and Clarity on Testing
12:00pm, Wednesday, 27'th May 2020
Bionano Genomics, Inc. (BNGO) today announced that Erik Holmlin, Ph.D., CEO of Bionano, will participate on a panel entitled: “Testing and Susceptibility – Clearing the Air,” during the virtual
Cancer Genomics Consortium Members Demonstrate 100% Concordance Between Bionano Saphyr and Gold Standard Cytogenetics in Leukemia
12:00pm, Tuesday, 19'th May 2020
Bionano Genomics, Inc. (BNGO) announced that in an online presentation hosted by the Cancer Genomics Consortium (CGC) on May 12, 2020, Dr. Brynn Levy from Columbia University and Dr. Rashmi Kanagal-Sh
Bionano Genomics to Report First Quarter 2020 Financial Results on June 18, 2020
08:30pm, Thursday, 14'th May 2020
Bionano Genomics, Inc. (BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and ultra-specific structural variation detection in genome an
Bionano Genomics, Inc. (BNGO) today announced the appointment of Hannah Mamuszka and Yvonne Linney, PhD, to its board of directors. Junfeng Wang, who originally joined the company’s board as a repr
